As of 2025-06-30, the Fair Value of Cellectis SA (ALCLS.PA) is -10.18 EUR. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.28 EUR, the upside of Cellectis SA is -895.59%.
With the market price of 1.28 EUR and our fair value calculation, Cellectis SA (ALCLS.PA) is not a good investment. Investing in ALCLS.PA stocks now will result in a potential loss of 895.59%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -81.07 | -114.20 | -106.14 | -101.06 | -36.76 | -87.85 |
| YoY growth | 20.59% | -40.86% | 7.06% | 4.79% | 63.62% | 11.04% |
| Market Cap (mil) | 92.28 |
| P/E | |
| Forward P/E |
| EPS | -1.08 |
| Avg earnings growth rate | 11.04% |
| TTM earnings | -77.94 |